Victory Capital Management’s Adaptimmune Therapeutics ADAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-2,922,819
Closed -$23.3M 2536
2020
Q3
$23.3M Buy
2,922,819
+1,006,439
+53% +$8.03M 0.03% 725
2020
Q2
$19.2M Buy
+1,916,380
New +$19.2M 0.03% 801